These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19211861)

  • 21. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Hoefnagels WA; van Reisen AG
    Ned Tijdschr Geneeskd; 2003 Feb; 147(6):267-8; author reply 268-9. PubMed ID: 12621983
    [No Abstract]   [Full Text] [Related]  

  • 22. Atrial fibrillation and atherothrombosis: the importance of anticoagulation.
    Escobar C; Barrios V
    Am Heart J; 2009 May; 157(5):e27; author reply e29. PubMed ID: 19376295
    [No Abstract]   [Full Text] [Related]  

  • 23. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE Registry.
    Hsu JC; Chan PS; Tang F; Maddox TM; Marcus GM
    JAMA Intern Med; 2015 Jun; 175(6):1062-5. PubMed ID: 25867280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The improved but unfinished business of stroke risk stratification in atrial fibrillation.
    Banerjee A; Marín F; Lip GY
    Rev Esp Cardiol; 2011 Aug; 64(8):639-41. PubMed ID: 21684058
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anticoagulants in non-rheumatic atrial fibrillation].
    van Gennip A; Hellemons-Boode B; Krebber T; Langenberg-Ledeboer M
    Ned Tijdschr Geneeskd; 1992 Jan; 136(4):195-6. PubMed ID: 1736135
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of thromboembolism in non-valvular atrial fibrillation].
    Coccheri S; Cosmi B
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):927-9. PubMed ID: 12497850
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anticoagulation and non-rheumatic auricular fibrillation].
    Rodríguez Cumplido D; Casajuana Brunet J; Botinas Martí M
    Aten Primaria; 1998 May; 21(8):553-5. PubMed ID: 9670584
    [No Abstract]   [Full Text] [Related]  

  • 29. Atrial fibrillation and thromboembolic risk in Greece.
    Korantzopoulos P; Andrikopoulos G; Vemmos K; Goudevenos JA; Vardas PE
    Hellenic J Cardiol; 2012; 53(1):48-54. PubMed ID: 22275743
    [No Abstract]   [Full Text] [Related]  

  • 30. Atrial fibrillation in the elderly.
    Wetzel U; Hindricks G; Piorkowski C
    Minerva Med; 2009 Apr; 100(2):145-50. PubMed ID: 19390500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombotic therapy in atrial fibrillation.
    Dunn M; Alexander J; de Silva R; Hildner F
    Chest; 1989 Feb; 95(2 Suppl):118S-127S. PubMed ID: 2644094
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of vascular events in atrial fibrillation.
    King A; Bhala N
    Lancet; 2007 Jan; 369(9556):106; author reply 106. PubMed ID: 17223471
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter by Barrios et al regarding article, "Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study".
    Barrios V; Escobar C; Echarri R
    Circulation; 2009 Nov; 120(18):e153; author reply e154. PubMed ID: 19884478
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation and the urologist.
    Ghani KR; Anson KM; Camm AJ
    BJU Int; 2004 Aug; 94(3):254-5. PubMed ID: 15291845
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel approach to the prevention of thromboembolism in atrial fibrillation.
    Ganjoo AK
    Tex Heart Inst J; 2001; 28(2):163. PubMed ID: 11453136
    [No Abstract]   [Full Text] [Related]  

  • 37. The risks of lone atrial fibrillation.
    N Engl J Med; 1988 Mar; 318(10):639-40. PubMed ID: 3344010
    [No Abstract]   [Full Text] [Related]  

  • 38. NO hope for patients with atrial fibrillation.
    Rubart M; Zipes DP
    Circulation; 2002 Nov; 106(22):2764-6. PubMed ID: 12450999
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention of thrombolitic compications with atrial fibrillation].
    Abuladze G; Jinjolia N; Narsia E; Abashidze R; Kajaia T
    Georgian Med News; 2008 Oct; (163):35-8. PubMed ID: 18997251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.